Latest! The price of Chinese medicine is generally rising, and the quality is improving

Medicine Network February 8th Recently, the price of Chinese medicine has attracted much attention, the price of Chinese herbal medicine has generally risen since 2020, the price increase after the fourth quarter is accelerating.
128 varieties rose in Price in January 2021, according to Drugcom.com Big Data Monitoring.
Among them, the larger increase was Wang did not stay, from 6.5 yuan to 12 yuan, up 84.6%, followed by Tianxian (North) and aquarium, from 30 yuan to 50 yuan, 15 yuan to 25 yuan, Lotus (Shandong) from 140 yuan to 220 yuan, white medicine from 18 yuan to 27 yuan.
(source: Drugcom) In addition, the increase in the mountain silver flower, purple flower, lotus (sulfur-free) and blood exhaustion are also higher price increases of varieties.
mountain silver flowers from 100 yuan to 140 yuan, purple flowers from 1000 yuan to 1400 yuan, lotus must rise from 150 yuan to 220 yuan, blood exhaustion from 270 yuan to 400 yuan.
(source: Pharmaceutical Network) in fact, as early as December last year, CCTV Financial Channel has reported on the price of Chinese herbal medicine.
reported that in Guangzhou Qingping Chinese herbal medicine market, there are Chinese herbal medicine wholesalers said that its operation of medicinal herbs, in the fourth quarter of 2020 almost all varieties are rising in price.
for the reasons for the rise in the price of Chinese herbal medicine, many businesses believe that more rain is one of the important reasons for the price increase.
According to CCTV Financial Report, guangdong Zhaoqing, a Chinese herbal medicine processing enterprise head also said that due to the 2020 precipitation is too much, the general harvest of Chinese herbal medicine is not as good as in previous years, resulting in tight supply, prices naturally rising.
the price of the company's coriander products has increased from about 15,000 yuan/tonne at the end of 2019 to about 38,000 yuan/tonne by the end of 2020, more than doubling.
addition, the industry generally believes that the new crown outbreak has blocked some imports of medicinal herbs, invisibly also pushed up the price of related Chinese herbal varieties.
According to a statistical analysis of 76 imported medicinal herbs by Tiantianyuntu Pharmaceuticals Big Data Studio, domestic imports of Chinese herbal medicines grew by an average of 3.23% annually from 2010 to 2019, but imports of Chinese medicinal herbs are expected to decline by 28.07 percent in 2020, or about 1018,000 tons, the lowest level in nearly 15 years.
(source: Tiantianyuntu Medicinal Big Data Studio) However, the Chinese herbal medicine market is a large variety, there are ups and downs.
analysis shows that there are still some Chinese herbal medicine prices are continuing to fall.
There are three main types: First, the production of overheated varieties, accounting for more than 70% of the fall in price varieties, such as Wu Zhuyu, lily, peppers, fennel, western red flowers, white and so on;
quality of Chinese herbal medicine is improving in addition to the price, the quality of Chinese medicine is also a topic of great concern to the whole society.
past, Chinese medicine tablets have become regulars on the list of unqualified medicines in the country and provinces, and some even the entire list is Chinese medicine tablets.
these found to be unqualified Chinese medicine tablets, there is no shortage of sources of some well-known large enterprises varieties.
years, under the strict supervision of the relevant departments, the overall quality of Chinese medicine has improved significantly.
December 30, 2020, the 2020 edition of the pharmacopeia has been officially implemented, of which, the Chinese medicine requirements for 33 banned pesticides can not be detected, Chinese medicine enterprises will face heavy metals, agricultural residues of the high standards of inspection requirements.
with the implementation of the new pharmacopeia, the pharmaceutical industry, especially the Chinese medicine industry, will usher in a major round of changes, the quality of Chinese medicine is expected to be further improved.
Seber Blue special author, senior figure in the Chinese herbal medicine industry, the recent article "under the new edition of the pharmacopeia, this market demand skyrocketed" also mentioned that after the implementation of the 2020 edition of the pharmacopeia, in Chinese herbal medicine, Chinese medicine drink tablets agricultural residues In terms of inspection pass rate, a number of third-party testing platform revealed the information figures are relatively close, according to feedback, in recent times the detection situation, the relevant plant-based medicinal herbs and Chinese medicine tablets agricultural residues are not as serious as feared in the past, the pass rate can reach about 90%.
With the new edition of the pharmacopeia on Chinese medicine, Chinese medicine drink tablets put forward higher requirements, will quickly eliminate a considerable number of unqualified Chinese herbal medicine, enterprises will also pay more attention to the source of raw materials control.
Industry generally believe that in the short term, the implementation of the new pharmacopeia may stimulate the price of Chinese herbal medicines, but in the long run, more stringent quality standards, will undoubtedly regulate the entire Chinese herbal medicine market more healthy development.
In addition to the price of medicinal herbs that meet the standards of the Pharmacopeia is expected to continue to rise, the following categories of Chinese herbal medicine prices are also expected to continue to rise in 2021, such as the reduction in the planting area and the original price is not high, vulnerable to disaster reduction of medicinal herbs, wild herbs and so on.